HF 4064 laid over after testimony urging a feasibility study of Minnesota's gene‑therapy ecosystem Committee heard HF 4064, a proposal for a feasibility study to map Minnesota's cell and gene therapy research, workforce and manufacturing capacity; university and Mayo Clinic scientists testified in favor, while members asked for fiscal and equity considerations and IRB/tribal review plans.

Minnesota is on the brink of becoming a national hub for cell and gene therapy, but first, a crucial feasibility study is needed to unlock its potential.

Click to read more!

#MN #EquityInHealthcare #CitizenPortal #MinnesotaGeneTherapy #ResearchDevelopment #HealthInnovation